Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?
Somaya Albhaisi, Arun J. Sanyal – 12 April 2021
Contrast‐Enhanced Ultrasound for Vascular Complications in the Transplant Liver
Shahrzad Sharafi, Bryan R. Foster, Alice Fung – 12 April 2021
Contrast‐Enhanced Ultrasound for Vascular Complications in the Transplant Liver
Shahrzad Sharafi, Bryan R. Foster, Alice Fung – 12 April 2021
Jaundice in Polycystic Liver Disease: More Than Meets the Eye
Danielle Brandman – 12 April 2021
Magnetic Resonance Imaging of Hepatic Adenoma Subtypes
Vincenzo K. Wong, Alice W. Fung, Khaled M. Elsayes – 12 April 2021
Masthead
12 April 2021
Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge
Dinghui Liu, Juan Pang, Weijuan Shao, Jianqiu Gu, Yong Zeng, Housheng Hansen He, Wenhua Ling, Xiaoxian Qian, Tianru Jin – 12 April 2021
Using Contrast‐Enhanced Ultrasound to Characterize Focal Liver Lesions
David T. Fetzer, Yuko Kono, Shuchi K. Rodgers – 12 April 2021
The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
Steven L. Flamm, Kimberly Brown, Hani M. Wadei, Robert S. Brown, Marcelo Kugelmas, Milagros Samaniego‐Picota, Patrizia Burra, Fred Poordad, Sammy Saab – 12 April 2021 – Acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]–AKI) is a severe and often fatal complication of end‐stage liver disease. The goals of treatment are to reverse renal failure and prolong survival in patients who are critically ill. However, interventions have limited efficacy, and mortality rates remain high.
Using LI‐RADS With Contrast‐Enhanced Ultrasound
Shuchi K. Rodgers, David T. Fetzer, Yuko Kono – 12 April 2021